April 3, 2017 / 4:24 PM / 4 months ago

BRIEF-Mauna Kea Technologies announces results of Cellvizio study

1 Min Read

April 3 (Reuters) - Mauna Kea Technologies SAS:

* Largest Cellvizio study to date demonstrates near perfect correlation with histology in key GI procedures

* Cellvizio histologic correlation above 90 pct for Barrett's esophagus, biliary strictures, and pancreatic cysts procedures

* Says results from this registry will provide an important data point in efforts to secure reimbursement for Cellvizio in France Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below